Transpharmation Logo
  • Contact Us

Models & Assays

Operant Based Tests

Rats may be trained to respond for food reward under a variety of schedules to study factors such as effect of an NCE on motivation for food. Because animals are typically well trained in these tasks, baseline performance can be tightly controlled and performance becomes predictable enabling robust baselines with which to study effects of an NCE.

Validation Data: Effect of lorcaserin (Belviq) on operant responding for food under a progressive ratio schedule of reinforcement
Effect of lorcaserin pretreatment on behaviours motivated by food

Effect of lorcaserin (0.3-1 mg/kg SC) pretreatment on behaviours motivated by food made available under a progressive ratio schedule of reinforcement. In this test the response requirement for food reward is increased with each successive reward. The critical measure is the break point, i.e at which response level will the animal cease to work for food. Lorcaserin reduced the break point for food under a progressive schedule of reinforcement consistent with a reduced motivation for food. The effect of lorcaserin wasreversed by the selective 5-HT2C receptor antagonist SB-242084 (SB). Data modified from: Higgins et al (2012) Neuropsychopharmacology 37: 1177-1191.

Company

  • Our Team
  • Publications
  • News
  • Careers
  • Animal Welfare
  • Privacy Policy
  • Accessibility Policy
  • Cookies Policy

Services

  • Abuse Liability / Substance Use Disorders
  • Alzheimer's Disease
  • Bioanalytical Studies
  • CNS Drug Disposition
  • Cognitive Assessment
  • Depression/Anxiety
  • Dermatology
  • EEG
  • Epilepsy
  • Essential Tremor
  • Imaging
  • Inflammatory Pain
  • Inflammation
  • Medical Cannabis
  • Metabolic Disorders
  • Migraine
  • Molecular Biomarkers
  • Multiple Sclerosis
  • Neuropathic Pain
  • Operant Platform
  • Osteoarthritis
  • Parkinson's Disease
  • PK/PD Studies
  • PK-Bridge
  • Psychedelics
  • PXB Mouse Studies
  • Safety Studies
  • Schizophrenia
  • Veterinary Research
North America
1-548-538-2371
Europe
+44 (0)130 440 3165
Contact us

© 2024 Transpharmation™. All Rights Reserved.
Sitemap
LinkedIn account
Youtube account